Among 200 patients, the probability of a more desirable day-70 outcome with two doses of intravenous dalbavancin versus 4 to ...

The results of a randomized clinical trial suggest that patients with serious bloodstream infections caused by Staphylococcus ...

An NIH-funded trial found that two IV doses of dalbavancin, given a week apart, were as safe and effective as 4–6 weeks of ...

When misuse and overuse of medicines is making infections difficult or impossible to treat, then are not we all at risk?

A CT scan of the patient's head showed that her right sinus cavities were so inflamed that they appeared opaque on the scan.

Amy Symington, 21, had to learn to walk again an abscess in her hip became septic and did not respond to antibiotic treatment ...

An update from Armata Pharmaceuticals ( ($ARMP) ) is now available. On August 11, 2025, Armata Pharmaceuticals entered into a secured credit ...

Antimicrobial resistance is a lurking threat in hospitals around the world. As more strains of bacteria and other microbes ...

Researchers have found an unexpected ally in the fight against superbugs: the fungi living right on your skin. In a discovery ...

A spider bite turned into a weeks-long, life-threatening medical ordeal for a 16-year-old boy in Iowa this summer, his family ...